(Total Views: 487)
Posted On: 07/02/2025 1:12:34 AM
Post# of 154881
Quote:
The question I think is what does he mean by "option". A followup question might be, will the DMSB see the PD-L1 data and if there is large upregulation, does that present an ethical imperative to add the option to add ICI treatment?
The DMSB would have access to all data and would have a statistician on the board to independently compile it. The "option" will almost certainly be whether to use ICIs since that would be the physician's choice. When shown the data from the mTNBC results it would be morally negligent for them not to.
(17)
(0)
